Home › Crohn's Disease › California › Westminster
Crohn's Disease clinical trials in Westminster, CA
4 studies for Crohn's Disease are looking for participants at sites in and around Westminster (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
RecruitingPhase 2
- United Medical Doctors - Los Alamitos /ID# 281125, Los Alamitos · 5 mi away
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
RecruitingPhase 3
- United Gastroenterologists, Los Alamitos · 5 mi away
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
RecruitingPhase 3
- United Medical Doctors - Los Alamitos, Los Alamitos · 5 mi away
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
RecruitingPhase 3
- United Medical Doctors, Los Alamitos · 5 mi away
About Crohn's Disease
Crohn's Disease can cause inflammation in any area from the mouth to the anus. Read about medicines, surgery or dietary management to treat symptoms.
More about Crohn's Disease on MedlinePlus
Crohn's Disease trials in other cities
- New York City, NY35 studies
- Boston, MA19 studies
- Miami, FL19 studies
- Cleveland, OH19 studies
- St. Louis, MO19 studies
- Tyler, TX17 studies
- Houston, TX17 studies
- Orlando, FL17 studies
- Atlanta, GA17 studies
- San Antonio, TX15 studies
- San Diego, CA15 studies
- Los Angeles, CA15 studies
Other studies in Westminster
- Non-Small Cell Lung Cancer8 studies
- Breast Cancer7 studies
- Obesity6 studies
- Schizophrenia5 studies
- Colorectal Cancer5 studies
- Ulcerative Colitis5 studies
- Type 2 Diabetes4 studies
- Overweight4 studies
- Stomach Cancer3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.